Prescription drug · ANDA
Triamcinolone Acetonide NDC 55150-385
Triamcinolone acetonide 40 mg/mL · Injection, Suspension · Intra-articular, Intramuscular, Soft tissue · Eugia US LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55150-385-01 | 55150038501 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-385-01) / 10 mL in 1 VIAL, MULTI-DOSEMarketed from Jul 5, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Triamcinolone Acetonide
- Generic name (nonproprietary)
- triamcinolone acetonide
- Active ingredients
- Triamcinolone acetonide — 40 mg/mL
- Dosage form
- Injection, Suspension
- Route
- Intra-articular, Intramuscular, Soft tissue
- Labeler
- Eugia US LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212400
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 55150-385_dab18c1a-6fc9-4427-b44f-e34e0168450eSPL ID dab18c1a-6fc9-4427-b44f-e34e0168450eSPL set ID d9abdda5-80e3-407c-b636-9cc5fc438098RxCUI 1085754UNII F446C597KAUPC 0355150384013, 0355150385010
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455150038501followed by a unit qualifier and the quantityPackage 55150-0385-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 212400
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Triamcinolone Acetonide | Triamcinolone acetonide 40 mg/mL | Injection, SuspensionIntra-articular, Intramuscular, Soft tissue | Eugia US LLC | 55150-384 |